{"nct_id":"NCT02206763","title":"Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)","status":"TERMINATED","status_verified_date":"2019-01","start_date":"2014-10-16","start_date_type":"ACTUAL","primary_completion_date":"2017-01-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}